Pyoderma gangrenosum in a patient with bullous systemic lupus erythematosus.
We report a 55-year-old woman with bullous systemic lupus erythematosus, who later developed pyoderma gangrenosum (PG). Dapsone was effective for the eruption of bullous bullous systemic lupus erythematosus but not for pyoderma gangrenosum. Cyclosporine was effective for the skin lesions of pyoderma gangrenosum. This is the first reported case of PG associated with bullous systemic lupus erythematosus.
Sakamoto
Taiko
T
Department of Dermatology, Fujieda Municipal General Hospital, 4-1-11 Surugadai, Fujieda, Shizuoka 426-8677, Japan.
Hashimoto
Takashi
T
Furukawa
Fukumi
F
D016572:Cyclosporine / Q000008:administration & dosage; D003622:Dapsone / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008178:Lupus Erythematosus, Cutaneous / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy; D008875:Middle Aged; D017511:Pyoderma Gangrenosum / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy; D012720:Severity of Illness Index; D012872:Skin Diseases, Vesiculobullous / Q000150:complications* / Q000175:diagnosis*; D016896:Treatment Outcome
D016572:Cyclosporine; D003622:Dapsone